This inventor holds 1 USPTO granted patent. Top assignee: Obigen Pharma, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Yueh-Chin Wu in Botulinum Toxin Research
Introduction
Yueh-Chin Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of botulinum toxin formulations. His work focuses on enhancing the safety and efficacy of these compounds for various applications.
Latest Patents
Yueh-Chin Wu holds a patent for a "Botulinum toxin type A complex, and formulation thereof and usage method therefor." This invention relates to a botulinum toxin type A complex that includes components such as HA70, HA17, HA33, NINH, and BoNT/A1. The complex has a molecular weight ranging from 740 to 790 kDa. Compared to existing botulinum toxin complexes, this innovation is smaller in molecular weight, offers higher safety, and maintains a comparable treatment effect. He has 1 patent to his name.
Career Highlights
Yueh-Chin Wu is associated with Obigen Pharma, Inc., where he continues to advance his research in botulinum toxin applications. His work is pivotal in the ongoing development of safer and more effective therapeutic options.
Collaborations
Some of his notable coworkers include Tzu-Wen Tsau and Yung-Kai Wang, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Yueh-Chin Wu's innovative work in botulinum toxin research exemplifies the potential for advancements in biotechnology. His contributions are paving the way for safer and more effective treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile